The offer includes a fresh issue of Rs 1,475 crore, along with an offer for sale (OFS) of Rs 2,750 crore. The company submitted its draft papers on August 27, 2024, and received an observation letter from the Securities and Exchange Board of India (Sebi) on November 28.
Ahead of Market: 10 things that will decide stock market action on Monday
Indian markets closed lower for the second straight week, dragged by weak earnings, US tariff threats, and global uncertainty. IT stocks underperformed while Glenmark Pharma